FTC sues major pharmacy profit supervisors above insulin rates The company introduced action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the checklist price of lifetime-saving insulin prescription drugs. Elevance lowers advice on ‘unparalleled’ Medicaid challenges Executives reported the inc... https://aya-healthcare-address05949.blogocial.com/healthcare-news-options-66593842